Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

8-epi-prostaglandin F2alpha MeSH Supplementary Concept Data 2025


MeSH Supplementary
8-epi-prostaglandin F2alpha
Unique ID
C075750
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C075750
Entry Term(s)
15-F(2t)-IsoP
15-F(2t)-isoprostane
15-F2t-IsoP
15-F2t-isoprostane
8-F(2t)-isoprostane
8-epi-PGF2 alpha
8-epi-PGF2alpha
8-epiprostaglandin F2alpha
8-iso-PGF(2alpha)
8-iso-PGF2alpha
8-isoprostaglandin F2alpha
8-isoprostane
isoprostaglandin F2alpha type-III
Pharm Action
Vasoconstrictor Agents
Registry Numbers
27415-26-5
155976-51-5
Related Numbers
155976-51-5
CAS Type 1 Name
Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,8beta,9alpha,11alpha,13E,15S)-
Heading Mapped to
Dinoprost / analogs & derivatives
Frequency
1900
Note
a potent preglomerular vasoconstrictor acting principally through thromboxane A2 receptor activation
Source
J Clin Invest 1992 Jul;90(1):136-41
Date of Entry
1992/08/20
Revision Date
2018/07/11
8-epi-prostaglandin F2alpha Preferred
8-isoprostaglandin F2alpha Related
page delivered in 0.004s